← Back to Search

Dietary Supplement

Extended Longevity Supplements for Aging

Phase 2
Waitlist Available
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing will compare the change in results after completion of intervention with baseline
Awards & highlights

Study Summary

This trial is testing a new protocol to see if it can help people live longer, healthier lives by measuring its effect on epigenetic age.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing will compare the change in results after completion of intervention with baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and testing will compare the change in results after completion of intervention with baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Epigenetic Age

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExtractsExperimental Treatment1 Intervention
The ingredients found in these serums are all naturally occurring ingredients extracted from a variety of plant species: Pinetonal, Thyvolve, Telogenic, Sentophagy, Inflasolve, Stemegenis, and CMEnhance

Find a Location

Who is running the clinical trial?

TruDiagnosticLead Sponsor
11 Previous Clinical Trials
471 Total Patients Enrolled
8 Trials studying Aging
361 Patients Enrolled for Aging

Media Library

Extracts found in the Extended Longevity supplements (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05296993 — Phase 2
Aging Research Study Groups: Extracts
Aging Clinical Trial 2023: Extracts found in the Extended Longevity supplements Highlights & Side Effects. Trial Name: NCT05296993 — Phase 2
Extracts found in the Extended Longevity supplements (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05296993 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I become involved in this research project?

"We are currently recruiting 15 individuals that are aged 55-75 and suffering from the effects of aging. The ideal candidate also meets the following requirements: 8 Men, 7 Women, ages 55-75, able to comply with treatment and laboratory tests, adequate immune system function."

Answered by AI

Have any of the components in Extended Longevity been cleared by the FDA?

"Although there is some evidence suggesting that the extracts found in Extended Longevity supplements are safe, Power has only given it a 2 because this is still a Phase 2 trial and there is no data yet supporting efficacy."

Answered by AI

Can patients still enroll in this experiment?

"Unfortunately, the information available on clinicaltrials.gov indicates that this particular trial is not looking for new patients at the moment. The study was originally posted on May 25th, 2021 but was last edited on May 9th, 2022. There are 252 other trials underway that are currently accepting patients if you're interested."

Answered by AI

Does this research include elderly patients in its demographics?

"The aim of this clinical trial is to enroll people who are in the age bracket of 55 years old to 75 years old."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Quantum Functional Medicine
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~4 spots leftby Apr 2025